American Diabetes Association “Standards of Medical Care in Diabetes” is based on a complete review of the relevant literature by a diverse group of highly trained clinicians and researchers. After weighing the quality of evidence, from rigorous double-blind clinical trials to expert opinion, recommendations are drafted, reviewed, and submitted for approval to the American Diabetes Association Executive Committee. To see the 2021 Standards, please visit professional.diabetes.org/SOC.

Join ADA's Chief Scientific and Medical Officer, Robert Gabbay, MD, PhD, for a presentation on the key updates and highlights from the Standards of Medical Care in Diabetes—2021. To access the webcast, please visit professional.diabetes.org/SOC.

In a series of short videos now available on the Clinical Diabetes website, Drs. Vivian Fonseca, Minisha Sood, and Rodolfo Galindo discuss the pathophysiological changes that occur during the progression of type 2 diabetes, with a particular focus on the key role of declining β-cell function, as well as the clinical characteristics—long duration of type 2 diabetes and A1C ≥9%—that are indicative of diminishing β-cell function. An executive summary and videos of the full panel can be found at clinical.diabetesjournals.org/content/combination-injectable-therapy.

The 35th Annual Clinical Conference on Diabetes will be held virtually on 10-13 June 2021. The ADA Clinical Conference is designed specifically for primary care physicians, physician assistants, nurse practitioners, pharmacists, nurses, psychologists, dietitians, certified diabetes educators, and other health care professionals who care for patients with diabetes or those at risk for diabetes and who manage diabetes-related complications. Registration is now open. For more information, please visit professional.diabetes.org/meeting/other/35th-annual-clinical-conference-diabetes.

The American Diabetes Association's 81st Scientific Sessions will take place as a virtual meeting on 25-29 June 2021. The Scientific Sessions offers researchers and health care professionals an exceptional opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. Advance registration is now open. Please visit professional.diabetes.org/scientific-sessions for further information.

Join the American Diabetes Association's 5K@ADA Virtual Challenge anytime during 25-27 June 2021. This virtual challenge, supported by Novo Nordisk, allows you to run (or walk) from any location of your choice and gives you the opportunity to raise public awareness about the importance of a healthy lifestyle. Registration is currently open. For more information, please visit professional.diabetes.org/meetings/5kada.

“Diabetes and COVID-19” is an online collection of articles on the Diabetes Care website featuring the latest studies, clinical observations, and commentaries on COVID-19 with specific relation to patients with diabetes. Topics include management of diabetes and its complications during the pandemic, blood glucose control and remote glucose monitoring, and outcomes in patients with hyperglycemia, cardiovascular risk, and obesity. This web page is updated regularly as relevant Diabetes Care articles are published online ahead of print. To access the collection, visit care.diabetesjournals.org/collection/diabetes-and-COVID19.

Diabetes Core Update is a monthly audio podcast devoted to presenting and discussing the latest clinically relevant articles from the American Diabetes Association's scholarly journals. Each episode is approximately 20 minutes long and presents 5-6 recently published articles. Diabetes Core Update podcasts are free and can be accessed through Apple Podcasts, Google Play, or RSS feed. Alternatively, tune in directly from our website at diabetesjournals.org/content/diabetes-core-update-podcasts.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.